A broad community of stakeholders, representing freemarket, family, faith, education, business, and judicial interests come together to speak with a clear and singular voice.
Taxpayers should not foot the bill for something that the private sector is already committed to doing through a free market approach.
Coalition letter thanking all five FCC Commissioners, Chairman Ajit Pai, Commissioner Mike O’Rielly, Commissioner Jessica Rosenworcel, Commissioner Brendan Carr, and Commissioner Geoffery Starks, and the entire FCC staff for their valuable work that should not be dismissed as “lost opportunities.”
In a coalition letter the signers urge President Trump to apply the same successful, deregulatory, market-based approach that he has championed in other policy areas to health care.
In this coalition letter, these organizations caution weaponizing antitrust for broader socioeconomic purposes would fundamentally alter the primary goal of antitrust, undermine the rule of law, and negatively impact consumers.
While originally intended to provide additional upport for families and businesses complying with government-mandated economic restrictions to address COVID-19, the policy of providing supplemental unemployment insurance has stifled our nation's recovery and is keeping Americans from returning to work.
An open letter to the American people from 75 participants in the Health Policy Consensus Group and other health care leaders providing important guidance to policymakers following lessons learned from the coronavirus crisis, especially the imperative for greater flexibility in our health sector.
Coalition Letter Regarding the Imposition of New Buy America Requirements for Medical Goods and Pharmaceutical Products
In this letter to the administration, economists from numerous organizations encourage the U.S. and its trading partners to pursue policies that make medical supplies more plentiful and affordable.
Coalition letter in opposition to lawmakers actions that would deny patents, exclusivity, and property rights to biomedical innovators working on vaccines, diagnostics, therapies, and cures for COVID-19.
If implemented, a Buy American mandate would disrupt existing supply chains, invite retaliatory actions from trading partners, and threaten timely access to medicines. In this current health crisis, such a mandate could even threaten our ability to adequately respond to the pandemic.